Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

BACKGROUND: Premature discontinuation of aromatase inhibitors (AIs) in breast cancer survivors compromises treatment outcomes. We aimed to evaluate whether patient-reported joint pain predicts premature discontinuation of AIs. METHODS: We conducted a retrospective cohort study of postmenopausal wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Chim, Kannie, Xie, Sharon X, Stricker, Carrie T, Li, Qing S, Gross, Robert, Farrar, John T, DeMichele, Angela, Mao, Jun J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847371/
https://www.ncbi.nlm.nih.gov/pubmed/24004677
http://dx.doi.org/10.1186/1471-2407-13-401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847371/
https://www.ncbi.nlm.nih.gov/pubmed/24004677
http://dx.doi.org/10.1186/1471-2407-13-401

Ejemplares similares